COCP Latest Press Releases

-- August 17, 2026 --

Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors Globe Newswire 11:17 AM

-- August 3, 2026 --

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health Globe Newswire 7:00 AM

-- June 3, 2026 --

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer Globe Newswire 7:00 AM

-- May 26, 2026 --

Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza Globe Newswire 8:00 AM

-- May 15, 2026 --

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results Globe Newswire 8:00 AM

-- April 30, 2026 --

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection Globe Newswire 4:05 PM

-- April 2, 2026 --

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive Globe Newswire 8:00 AM

-- March 31, 2026 --

Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software